Connection

Maurizio Sanguinetti to Gastrointestinal Microbiome

This is a "connection" page, showing publications Maurizio Sanguinetti has written about Gastrointestinal Microbiome.
  1. Anti-tumor necrosis factor a therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis. World J Gastroenterol. 2019 Mar 28; 25(12):1465-1477.
    View in: PubMed
    Score: 0.074
  2. Liver Injury, Endotoxemia, and Their Relationship to Intestinal Microbiota Composition in Alcohol-Preferring Rats. Alcohol Clin Exp Res. 2018 12; 42(12):2313-2325.
    View in: PubMed
    Score: 0.072
  3. Influence of hepatitis C virus eradication with direct-acting antivirals on the gut microbiota in patients with cirrhosis. Aliment Pharmacol Ther. 2018 12; 48(11-12):1301-1311.
    View in: PubMed
    Score: 0.072
  4. Hepatocellular Carcinoma Is Associated With Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver Disease. Hepatology. 2019 01; 69(1):107-120.
    View in: PubMed
    Score: 0.071
  5. Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders. Dig Dis. 2018; 36(1):56-65.
    View in: PubMed
    Score: 0.066
  6. Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic. Gut. 2020 09; 69(9):1555-1563.
    View in: PubMed
    Score: 0.020
  7. Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a 3-year, single-centre cohort study. Clin Microbiol Infect. 2017 May; 23(5):337.e1-337.e3.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.